PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma

International Journal of Oncology

Volumn 42, Issue 4, 2013, Pages 1408-1416

  Yco, Lisette P ^a,b   Geerts, Dirk ^d,e   Koster, Jan ^d   Bachmann, André S ^a,b,c  

^a UNIVERSITY OF HAWAII AT HILO   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Cell proliferation; Member 2; Metastasis; Neuroblastoma; Patient survival; Pediatric cancer; Prenylated Rab acceptor 1 domain family

Indexed keywords

MESSENGER RNA; PRENYLATED RAB ACCEPTOR 1 DOMAIN FAMILY MEMBER 2; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

AGE; ARTICLE; BONE MARROW METASTASIS; BONE METASTASIS; CAUSE OF DEATH; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE AMPLIFICATION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEUROBLASTOMA CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE;

CARRIER PROTEINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; G1 PHASE CELL CYCLE CHECKPOINTS; GENE DOSAGE; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MEMBRANE PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; RNA, SMALL INTERFERING;

EID: 84874608865     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1836     Document Type: Article

References (30)

1. Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216, 2003.
2. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369:2106-2120, 2007.
3. Schweneker M, Bachmann AS and Moelling K: JM4 is a fourtransmembrane protein binding to the CCR5 receptor. FEBS Lett 579:1751-1758, 2005.
4. Fo CS, Coleman CS, Wallick CJ, Vine AL and Bachmann AS: Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2). Gene 371:154-165, 2006.
5. Bachmann AS, Duennebier FF and Mocz G: Genomic organization, characterization, and molecular 3D model of GDE1, a novel mammalian glycerophosphoinositol phosphodiesterase. Gene 371:144-153, 2006.
6. Koomoa DL, Go RC, Wester K and Bachmann AS: Expression profile of PRAF2 in the human brain and enrichment in synaptic vesicles. Neurosci Lett 436:171-176, 2008.
7. Borsics T, Lundberg E, Geerts D, et al: Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: influence on cell survival and migration. Cancer Sci 101:1624-1631, 2010.
8. Sivars U, Aivazian D and Pfeffer SR: Yip3 catalyses the dissociation of endosomal Rab-GDI complexes. Nature 425:856-859, 2003.
9. Compton SL and Behrend EN: PRAF1: a Golgi complex transmembrane protein that interacts with viruses. Biochem Cell Biol 84:940-948, 2006.
10. Compton SL, Kemppainen RJ and Behrend EN: Prenylated Rab acceptor domain family member 1 is involved in stimulated ACTH secretion and inhibition. Cell Signal 21:1901-1909, 2009.
11. Kim JT, Cho MY, Choi SC, et al: Prenylated Rab acceptor 1 (PRA1) inhibits TCF/beta-catenin signaling by binding to betacatenin. Biochem Biophys Res Commun 349:200-208, 2006.
12. Li LY, Shih HM, Liu MY and Chen JY: The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J Biol Chem 276:27354-27362, 2001.
13. Liu HP, Wu CC and Chang YS: PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1. EMBO J 25:4120-4130, 2006.
14. Lin CI, Orlov I, Ruggiero AM, et al: Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature 410:84-88, 2001.
15. Mao WG, Liu ZL, Chen R, Li AP and Zhou JW: JWA is required for the antiproliferative and pro-apoptotic effects of all-trans retinoic acid in HeLa cells. Clin Exp Pharmacol Physiol 33:816-824, 2006.
16. Chen H, Bai J, Ye J, et al: JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cell Signal 19:1315-1327, 2007.
17. Geerts D, Wallick CJ, Koomoa DL, et al: Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation. Clin Cancer Res 13:6312-6319, 2007.
18. Valster A, Tran NL, Nakada M, Berens ME, Chan AY and Symons M: Cell migration and invasion assays. Methods 37:208-215, 2005.
19. Fardin P, Barla A, Mosci S, et al: A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Mol Cancer 9:185, 2010.
20. Revet I, Huizenga G, Chan A, et al: The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma. Exp Cell Res 314:707-719, 2008.
21. Barrett T, Troup DB, Wilhite SE, et al: NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 37:D885-D890, 2009.
22. Bewick V, Cheek L and Ball J: Statistics review 12: survival analysis. Crit Care 8:389-394, 2004.
23. Vento MT, Zazzu V, Loffreda A, et al: Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cell. PLoS One 5:e15636, 2010.
24. Malumbres M and Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9:153-166, 2009.
25. Molenaar JJ, Koster J, Ebus ME, et al: Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis. Genes Chromosomes Cancer 51:10-19, 2012.
26. Bai J, Zhang J, Wu J, et al: JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling. Oncogene 29:1227-1237, 2010.
27. Hynes RO: Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants - or both? Cell 113:821-823, 2003.
28. Hendrix A, Westbroek W, Bracke M and De Wever O: An ex (o) citing machinery for invasive tumor growth. Cancer Res 70:9533-9537, 2010.
29. Peinado H, Lavotshkin S and Lyden D: The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol 21:139-146, 2011.
30. Shi GZ, Yuan Y, Jiang GJ, et al: PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma. BMC Cancer 12:97, 2012.